晋城市美甲加盟哪家好电话多少钱厦门市ak美甲加盟电话多少钱,曲靖市馨米兰美甲加盟电话多少钱,扬州市印奈儿美甲加盟电话多少钱,德州市莎茜美甲加盟电话多少钱,无锡市喵小姐美甲加盟电话多少钱,大连市发下美甲加盟电话多少钱,大连市晴湾美甲加盟电话多少钱

President-elect Joe Biden met with his Transition Team's COVID-19 Advisory board for the first time on Monday morning, and delivered remarks following the meeting."I will spare no effort to turn this pandemic around when I'm sworn in on Jan. 20," Biden said.In his remarks, Biden congratulated Pfizer on the company's Monday announcement that early studies show its vaccine candidate is 90% effective in fighting the virus. However, Biden cautioned that even in best-case scenarios, the vaccine won't widely be available for several months. He promised that once vaccine candidates are approved, he will ensure that doses are distributed safely and efficiently.In addition, Biden called on manufactures to ramp up production of personal protective equipment and also said he planned to order more rapid test kits for use across the country.Finally, Biden spent several moments promoting the use of masks, calling them "the most potent weapon against the virus."It doesn't matter who you voted for...it doesn't matter your party or point of view," Biden said. "We could save tens of thousands of lives in the next few months if everyone just wears a mask."The address in Wilmington, Delaware came hours after Biden and Vice President-elect Kamala Harris announced the formation of a COVID-19 Advisory Board as part of their administration's White House Transition Team.The Biden-Harris Transition team said the board would consist of public health experts who will advise both Biden and Harris.“Dealing with the coronavirus pandemic is one of the most important battles our administration will face, and I will be informed by science and by experts,” Biden said in a press release “The advisory board will help shape my approach to managing the surge in reported infections; ensuring vaccines are safe, effective, and distributed efficiently, equitably, and free; and protecting at-risk populations.”The board consists of:CO-CHAIRSDr. David Kessler: Professor of Pediatrics and Epidemiology and Biostatistics at UCSF. He served as FDA commisioner from 1990-1997.Dr. Vivek Murthy: Served as 19th Surgeon General of the United States from 2014-2017.Dr. Marcella Nunez-Smith: Associate Professor of Internal Medicine, Public Health, and Management at Yale University and the Associate Dean for Health Equity Research at the Yale School of Medicine.MEMBERSDr. Luciana Borio: VP of Technical Staff at In-Q-Tel. She is also a senior fellow for global health at the Council on Foreign Relations.Dr. Rick Bright: Immunologist, virologist and former public health official.Dr. Ezekiel Emanuel: Oncologist and Vice Provost for Global Initiatives and chair of the Department of Medical Ethics and Health Policy at the University of Pennsylvania.Dr. Atul Gawande: Cyndy and John Fish Distinguished Professor of Surgery at Brigham and Women’s Hospital, Samuel O. Thier Professor of Surgery at Harvard Medical School, and Professor of Health Policy and Management at Harvard T.H. Chan School of Public Health.Dr. Celine Gounder: Clinical Assistant Professor at the NYU Grossman School of Medicine and cares for patients at Bellevue Hospital Center.Dr. Julie Morita: Executive Vice President of the Robert Wood Johnson Foundation (RWJF).Dr. Michael Osterholm: Regents Professor, McKnight Presidential Endowed Chair in Public Health and the director of the Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota.Ms. Loyce Pace: Executive Director and President of Global Health Council.Dr. Robert Rodriguez: Professor of Emergency Medicine at the UCSF School of Medicine.Dr. Eric Goosby: Professor of Medicine at the UCSF School of Medicine.This story was originally published by WXYZ in Detroit. 3722

President Donald Trump’s physical Dr. Sean Conley confirmed Friday that the president is taking an experimental antibody treatment to help him fight the coronavirus following his diagnosis this morning.Dr. Conley said Friday afternoon that Trump is "fatigued."Trump is taking the Regeneron antibody cocktail, which is currently in a clinical trial. Conley said that Trump has been treated with a single 8 gram dose, which Conley said was infused "without incident."Trump is also said to be taking Vitamin D, zinc, famotidine, melatonin and daily aspirin. The Regeneron trial has only been tried on 275 patients as of this week, but the company said earlier this week that it has showed promising results.Regeneron confirmed that Trump was given the treatment under a "compassionate use request.""In the USA, this type of compassionate use program is also known as an Expanded Access Program (EAP) and is intended for patients with serious or life-threatening conditions, who do not have any viable or available treatment options, and are unable to participate in ongoing clinical trials," Regeneron said in a statement. The plan is to enroll 2,000 patients in early studies of the treatment."After months of incredibly hard work by our talented team, we are extremely gratified to see that Regeneron's antibody cocktail REGN-COV2 rapidly reduced viral load and associated symptoms in infected COVID-19 patients," said George D. Yancopoulos, M.D., Ph.D., President and Chief Scientific Officer of Regeneron. "The greatest treatment benefit was in patients who had not mounted their own effective immune response, suggesting that REGN-COV2 could provide a therapeutic substitute for the naturally-occurring immune response. These patients were less likely to clear the virus on their own, and were at greater risk for prolonged symptoms.The treatment is a combination of two monoclonal and was designed specifically to block infectivity of SARS-CoV-2, the virus that causes COVID-19, the company said.“The two potent, virus-neutralizing antibodies that form REGN-COV2 bind non-competitively to the critical receptor binding domain of the virus's spike protein, which diminishes the ability of mutant viruses to escape treatment and protects against spike variants that have arisen in the human population, as detailed in Science.” Regeneron said in a statement. “Preclinical studies have shown that REGN-COV2 reduced the amount of virus and associated damage in the lungs of non-human primates.”According to Regeneron, the treatment has been tried on hospitalized and non-hospitalized patients and as a preventative for those who have had close contact with coronavirus patients. So far, the drug has been particularly promising for non-hospitalized patients.Regeneron said the treatment reduces the viral load from the coronavirus, and boosts the body’s immune response to the virus. 2890

Press conference for the #BondFire scheduled for 3 p.m. at the Incident Command Post at Irvine Great Park. We will be live streaming on our Facebook: https://t.co/vQXoKJzdOY pic.twitter.com/vEYW3rcfOr— OCFA PIO (@OCFA_PIO) December 3, 2020 247

RAINBOW, Calif. (KGTV) - A new overpass may be destined for the I-15, not for people but mountain lions.A just-released study led by The Nature Conservancy and backed by the National Park Service recommended a stretch of the I-15 just south of Temecula - either an overpass or underpass like crossings in Colorado, Utah and Wyoming - allowing mountain lions and other wildlife to safely get across.On the west side of the highway is preserve space owned by San Diego State University.  On the other side are 73 acres just purchased by The Nature Conservancy.  Experts says the local mountain lions have been cut off by the freeways and are practicing inbreeding."That makes them more susceptible to disease, and that could be catastrophic for the mountain lion population," said Cara Lacey, an associate program director at The Nature Conservancy.Lacey points out crossings in other states have also cut down on vehicle collisions with wildlife.  She says at least three mountain lions were struck by vehicles in that stretch of I-15 in 2017.  Caltrans is studying a crossing on Highway 101, which would cost between and million. 1165

President Donald Trump was infuriated after it quickly leaked that he had been directly instructed by his national security advisers in briefing materials not to congratulate Russian President Vladimir Putin on his recent election victory during their call Tuesday morning, a source familiar with the President's thinking said.Trump was fuming Tuesday night, asking his allies and outside advisers who they thought had leaked the information, noting that only a small group of staffers have access to those materials and would have known what guidance was included for the Putin call, the source said.According to the source, the incident resurfaces his long-held belief there are individuals inside his administration -- especially in the national security realm -- who are actively working to undermine him. 817